To whom correspondence should be addressed liver carcinomas in various animal species (9) and that NDMA The alkylation of DNA, RNA and protein by labeled also causes kidney tumors in rats and mice (10), NDPA metabolites of [α-14 C]nitrosodimethylamine (NDMA), [α-primarily induces pancreatic cancers in rats and hamsters 14 C]nitrosodipropylamine (NDPA) and [α-14 C]nitrosodibuwhereas NDBA induces tumors of the urinary bladder in rats, tylamine (NDBA) was determined as a measure of the mice, hamsters and guinea pigs (9,11). metabolic activation of these nitrosamine carcinogens Studies on the biochemical mechanisms of action of the in vitro using microsomes prepared from freshly isolated nitrosodialkylamines have led to the conclusion that the carcirat hepatocytes as well as in intact cells using primary nogenicity, cytotoxicity and mutagenicity produced by nitrosocultured rat hepatocytes. The abilities of these nitrosodialkdialkylamines are due to their metabolic conversion to reactive ylamines to alkylate cellular macromolecules were significelectrophiles (12). Results from in vitro studies on the antly affected by pretreatment of rats with inducers of enzymatic nature of nitrosodialkylamine metabolism using cytochrome P450 and were related to the specific activities liver microsomes and the reconstituted system with either of cytochrome P450 2B1 or 2E1 in rat hepatocytes. Prepurified isoforms of cytochrome P450 or the cDNA-expressed treatment of rats with phenobarbital (PB) substantially human cytochrome P450 isoforms have demonstrated the increased the catalytic activity of pentoxyresorufin (PR) Oinvolvement of cytochrome P450 in the metabolism of these depentylase, an activity catalyzed by cytochrome P450 2B1, nitrosodialkylamines. We have previously shown that in rat hepatocytes. The increase in the PR O-depentylase cytochrome P450 2E1 appears to play a major role in the activity was associated with a significant increase in the metabolic activation of short chain nitrosodialkylamines such alkylation of DNA or RNA by NDPA, and in alkylation by as NDMA whereas cytochrome P450 2B1 is involved in the NDBA, particularly of proteins. However, induction of metabolism of the longer chain nitrosodialkylamines NDPA cytochrome P450 2B1 resulted in a significant decrease in and NDBA (13-16). In the carcinogenicity and cytotoxicity alkylation of cellular macromolecules by NDMA in all studies with primary cultured rat hepatocytes, cytochromes cases. In contrast, enhancement of the catalytic activity of P450 2B1 and 2E1 have been demonstrated to play important the p-nitrophenol (pNP) hydroxylase (P450 2E1) due to roles in the modulation of DNA damage-repair induced by pretreatment of rats with pyridine (PYR) resulted in a NDMA, NDPA and NDBA (17). significant increase in the alkylation of cellular DNA by Although the exact mechanisms by which the reactive NDMA. The induction of cytochrome P450 2E1 also metabolites cause the observed tissue changes have not yet been increased the alkylation of DNA and RNA by NDPA, but elucidated, irreversible binding of the reactive intermediates to to a lesser extent. Inhibition studies using the chemical critical nucleophilic sites of tissue macromolecules is believed inhibitors orphenadrine (OP) and diethyldithiocarbamate to be involved (18, 19) . Therefore, the possibility that the (DDC), which are specific for cytochromes P450 2B1 and carcinogenic or cytotoxic action of NDMA, NDPA and NDBA 2E1, respectively, indicated that cytochrome P450 2B1 was may be related to their ability to be metabolically activated not involved in the metabolic activation of NDMA and by cytochrome P450 to form alkylating agents in vitro and in that cytochrome P450 2E1 was not responsible for the cultured hepatocytes was investigated in this study. bioactivation of NDBA. The results presented here demonSince α-hydroxylation has been shown to be a principle strate the substrate specificity and important role of pathway for the in vitro metabolism of NDMA, NDPA and cytochromes P450 2B1 and 2E1 in the bioactivation of NBPA (16, 20) , and is also thought to be an important bioactivnitrosodialkylamines, and suggest that multiple mechanation route for these nitrosodialkylamines in liver (21-23), all isms may be involved in carcinogenesis induced by nitrosoof the nitrosamines used in these studies (NDMA, NDPA and dialkylamines.
NDBA) were obtained radiolabeled with 14 C on the α-carbons adjacent to the nitroso group. We have previously identified cytochromes P450 2B1 and 2E1 as the two primary isoforms Introduction involved in the metabolism of NDPA and NDBA (16), and The nitrosamines N-nitrosodimethylamine (NDMA*), N-nitroalso demonstrated that the ability of NDMA, NDPA and sodipropylamine (NDPA) and N-nitrosodibutylamine (NDBA)
NDBA to damage DNA correlated with the specific activity are widely distributed as contaminants in a variety of foods, of cytochrome P450 2B1 or 2E1 (21). Here, we focused on alcoholic beverages, tobacco and its smoke, herbicides, pestistudies on the role of these two isoforms of cytochrome P450 in the bioactivation of NDMA, NDPA and NDBA to form and has no significant effect on the activity of cytochromes P450 2B1 and intracellular macromolecules, DNA, RNA and protein, were 2E1 at the concentrations used for these studies (17 The total DNA, RNA and protein were simultaneously isolated from cultured was also investigated using primary cultured hepatocytes hepatocytes from pretreated or untreated rats using TRIzol Reagent, a isolated from untreated and pretreated rats.
commercial reagent for the isolation of total RNA (25) using the recommended
The substrate specificity and the contributions of cytochrome protocol with some modifications. Cells were lysed directly in the culture P450 2B1 and 2E1 to the bioactivation of these three nitrosodi- Microsomes were prepared from hepatocytes freshly isolated from untreated Animal treatment and pretreated rats. The isolated cells were precipitated by centrifugation at Male Fischer-344 rats weighing 250-275 g were purchased from Harlan 1000 g for 3 min. The cell pellets were resuspended in hypotonic buffer (10 Sprague-Dawley Company (Indianapolis, IN). Standard rat chow and tap mM Tris, 50 mM EDTA and 10 mM KCl) and incubated for 10 min on ice water were given ad libitum for 3 days prior to treatment. Treated rats received to allow the cells to swell. The homogenization buffer consisting of 0.1 M either 0.1% PB in the drinking water for 10 days or PYR by i.p. injection potassium phosphate (pH 7.3), 0.15 M KCl, 1 mM EDTA and 0.25 mM (100 mg/kg per day) for 3 consecutive days. Control rats did not receive phenylmethylsulfonyl fluoride was then added and the cells were lysed by any treatment.
brief sonication on ice (2ϫ20 s). Microsomes were prepared by differential Cell and culture conditions centrifugation (28) and stored at -80°C in microsomal suspension buffer containing 0.1 M potassium phosphate (pH 7.4), 1 mM EDTA and 20% Hepatocytes were isolated from untreated or pretreated rats using the twoglycerol. Microsomal protein concentrations were determined using the BCA step in situ collagenase perfusion procedure described by Schuetz and Guzelian assay (27) . (24) with some modifications. Rats, without fasting before being killed, were anesthetized with sodium pentobarbital (64.8 mg/ml) using doses from 100
Alkylation of DNA and proteins by NDMA, NDPA or NDBA in vitro to 200 mg/kg body weight depending on the pretreatment of rats. The liver Alkylation of DNA and proteins by nitrosamines in vitro was determined was first perfused through the portal vein with calcium-free Earle's Balanced using the conditions for the microsomal dealkylation assay (20). Briefly, in a Salt Solution, pH 7.4, containing 5.3 mM KCl, 117 mM NaCl, 26 mM total volume of 200 µl, the reaction mixture contained 0.3 mg microsomal NaHCO 3 , 1 mM NaH 2 PO 4 , 5.6 mM D-glucose and 0.5 mM EGTA for [3] [4] [5] proteins, 15 µg calf thymus DNA dissolved in H 2 O and 0.1 mM [α-min followed by a secondary perfusion with 92.5 mg collagenase/250 ml 14 C]NDMA, NDPA or NDBA. For the inhibition studies, the reaction mixtures WME buffer for 10 min. The hepatocytes were separated from connective were preincubated with the inhibitor (OP, DDC or PYZ) for 10 min at RT. tissue by filtering through gauze (twice) and from non-parenchymal cells by
The reactions were initiated by adding an NADPH-regenerating system and repeated low speed centrifugation (50 g) (three times). Cells (500-600) were run in 50 mM Tris-HCl buffer (pH 7.4) containing 150 mM KCl and 10 mM counted under the microscope and the viability, assessed by exclusion of MgCl 2 at 37°C. They were terminated at the time points indicated, or at 60 trypan blue, ranged from 89 to 96%. Following isolation, the hepatocytes min for inhibition assays, by the addition of 7 µl of stop solution containing were suspended in WME supplemented with 4% fetal bovine serum, penicillin-500 mM EDTA (pH 8) and 10% SDS (6:1) (29). DNA was extracted by using streptomycin-glutamine (100 U/ml-100 µg/ml-0.3 mg/ml) and 1 µg/ml insulin an equal volume of phenol. DNA extracts were precipitated by adding 1/10 as the only hormone. Aliquots of the cell suspension (3ϫ10 6 cells) were of the total volume of 3 M Na-acetate (pH 5.5), they were stored at -80°C inoculated into 35-mm tissue-culture dishes precoated with collagen. After for 30 min and centrifuged at 16 000 g for 15 min. Proteins were precipitated 1.5 h for attachment at 35°C, non-viable cells were removed by a medium by adding 1 ml of 100% ethanol and centrifuged at 11 750 g for 10 min. The change. Sample cultures were treated with [α-14 C]NDMA (0.1 mCi/ml), resulting DNA or protein pellets were washed using ethanol-ether (3:1) [α-14 C]NDPA (0.87 mCi/ml) or [α-14 C]NDBA (0.85 mCi/ml) at a final solution. The washings were repeated until virtually no radioactivity was concentration of 20 µM, unless otherwise indicated. This dose was selected detected in the washings (usually three to four times). The DNA pellets were since it was the maximum amount of nitrosamine that could be used without resuspended in H 2 O, and the protein pellets were resuspended in Solvable. observing significant levels of toxicity for the hepatocytes. Control cultures received acetonitrile alone, which is not a substrate for cytochrome P450s
The covalently bound radioactivity was determined in Ultima-Gold scintillation fluid (Packard Instrument Co., Meriden, CT) by counting on a Beckman LS-5800 counter (Beckman Inc., Arlington Heights, IL).
Enzyme activity assays
The rate of hydroxylation of p-nitrophenol was determined according to the method described by Koop (30) . The 7-pentoxyresorufin O-depentylase activity of hepatic microsomes was determined using the method of Burke et al. (31) . The formation of 7-hydroxyresorufin was continuously monitored on an SLM/ Aminco SRF-500C spectrofluorometer (Milton Roy, Rochester, NY) using the slow time course program (1 min run) with excitation and emission wavelengths of 522 and 586 nm, respectively. For these assays we used an NADPHregenerating system instead of NADPH to initiate the reactions. Under the same conditions, we found that the activities of both the pNP hydroxylase and 7-pentoxyresorufin O-depentylase increased 10-20% in the reactions with an NADPH-regenerating system compared to those with NADPH (data not shown). For the inhibition studies, the reaction mixtures were preincubated with inhibitor (OP, chloramphenicol, DDC, 4-methylpyrazole, PYZ or PYR) Fig. 1 . Time course and effects of induction of cytochrome P450 on DNA for 10 min at RT before the addition of the nitrosamine substrate.
alkylation by NDMA (d), NDPA (m) or NDBA (s) in microsomes Statistical evaluation of the results prepared from hepatocytes isolated from untreated (A), PB-(B) or PYRResults are expressed as the mean Ϯ SD. Differences between two groups pretreated (C) rats. The preparation of hepatic microsomes and were examined using the Student's t-test, and the comparisons of multiple determinations of DNA binding were performed as described in Materials groups were performed by using analysis of variance. A P Ͻ 0.05 was and methods. Data are taken from three separate experiments with each considered significant. point determined in triplicate. Bars are SD of the mean. In (B) and (C) all of the time points for NDMA, NDPA and NDBA were significantly different (P Ͻ 0.05) from corresponding values in (A) except for NDBA at
Results

and 40 min in (C).
The studies on the ability of labeled nitrosodialkylamines to alkylate cellular macromolecules were first performed in vitro using hepatic microsomes from untreated, PB-and PYRpretreated rats. Calf thymus DNA was added to the microsomal incubations and, following the reaction, the microsomal proteins and calf thymus DNA were recovered simultaneously from the same reaction. Two different controls were used for all experiments, one in which the NADPH-regenerating system was absent and the other in which the microsomes were omitted. After a 20-min incubation, no radioactivity above background was associated with either the calf thymus DNA or the microsomal proteins recovered from either of these controls (data not shown), indicating that the parent nitrosamines (NDMA, NDPA and NDBA) are unable to bind to microsomal proteins and calf thymus DNA in the absence relatively more radioactivity than that from microsomes incubated with NDBA ( Figure 1A ). The pattern of DNA alkylation, however, was significantly altered when microsomes from NDBA was slower in all cases. No further increase in DNA alkylation by NDPA was observed after~90 min, while PB-pretreated rats were used. PB pretreatment significantly enhanced the activity of hepatic microsomes for catalyzing alkylation of DNA by NDBA did not level off until almost 110 min after initiation of the reaction. DNA alkylation by NDPA and NDBA, up to two-and threefold, respectively ( Figure 1B) . On the other hand, pretreatment
The time courses for the alkylation of microsomal proteins by reactive metabolites of NDMA, NDPA and NDBA are of rats with PB significantly decreased DNA alkylation by NDMA. Incubation of labeled NDMA or NDPA with hepatic shown in Figure 2 . It can be seen that the time courses for the 14 C labeling of the microsomal proteins varied depending on microsomes from PYR-pretreated rats resulted in the highest levels of formation of radioactive DNA adducts ( Figure 1C) . substrate and the variations were generally similar to those observed for DNA alkylation by these nitrosodialkylamines. PYR pretreatment also increased DNA alkylation by NDBA, but to a lesser extent.
With hepatic microsomes from untreated rats, all of the tested nitrosamines produced low levels of radiolabeled proteins Studies on the time course for calf thymus DNA alkylation shown in Figure 1 reveal that NDMA was rapidly metabolized (Figure 2A ). However, a substantial increase in protein alkylation was observed when NDBA was incubated with by hepatic microsomes with no further increase in DNA alkylation observed after 50-60 min regardless of the pretreathepatic microsomes from PB-pretreated rats. This increase in protein alkylation did not occur with NDPA under the identical ment. The alkylation of calf thymus DNA by NDPA and experimental conditions ( Figure 2B ). As was observed for increase in the activity of PR O-depentylase activity, PYR treatment primarily enhanced the activity of pNP hydroxylase DNA alkylation, hepatic microsomes from PB-pretreated rats exhibited decreased alkylation of microsomal proteins by of hepatic microsomes (Table I ). The cytochrome P450 2E1-associated activity in PYR microsomes was inhibited 95% by NDMA ( Figure 2B ). Pretreatment of rats with PYR resulted in a marked increase in the formation of protein adducts with 200 µM DDC. Alkylation of calf thymus DNA and microsomal proteins NDMA but PYR pretreatment did not increase the radiolabeling of microsomal proteins by NDPA and NDBA ( Figure 2C ).
by NDMA in hepatic microsomes from untreated and PYRpretreated rats was greatly inhibited (up to 90%) by DDC but The relationship between alkylation by NDMA, NDPA or NDBA and the specific activity of cytochrome P450 2B1 or not by OP ( Figure 3A) . However, in hepatic microsomes from PB-pretreated rats, the low levels of DNA and protein alkylation 2E1 was investigated by measuring the cytochrome P450 2B1-and 2E1-associated activities in different microsomal by NDMA were not inhibited by DDC at all ( Figure 3A ). The alkylation of calf thymus DNA and microsomal proteins by preparations with or without inhibitors of P450 2B1 or 2E1 and relating them to the alkylating activities. Although a NDPA was markedly decreased in microsomes from both PBand PYR-pretreated rats in the presence of OP ( Figure 3B ). number of inhibitors have been reported to be specific inhibitors of cytochrome P450 2B1 or P450 2E1 (32), their potency and DDC significantly inhibited DNA alkylation by NDPA in microsomes from PYR-pretreated rats and showed no inhibition specificity for cytochrome P450 2B1 or 2E1 in the systems we are studying had not been well characterized. Therefore, in control microsomes ( Figure 3B ). Both DNA and protein alkylation by NDBA were effectively inhibited by co-incubawe determined the inhibitory activities of a number of inhibitors for the cytochrome P450 2B1 or 2E1 activities in the different tion with OP, except for DNA alkylation in control microsomes ( Figure 3C ). microsomal preparations. As an inhibitor of PR O-depentylase activity, a measure of cytochrome P450 2B1, OP was found To investigate the cellular alkylating activities and possible specificities of the individual nitrosodialkylamines for to be more potent and specific than chloramphenicol (data not shown). Among all of the cytochrome P450 2E1 inhibitors intracellular targets, the alkylation of the three major cellular macromolecules (DNA, RNA and protein) by NDMA, NDPA examined in this study for the inhibition of pNP hydroxylation activity (DDC, 4-methylpyrazole, PYZ and PYR), DDC exhiband NDBA was investigated using primary cultured rat hepatocytes. Figure 4 shows the time courses for the alkylation of ited the best specificity and potency for cytochrome P450 2E1 (data not shown).
hepatocyte DNA, RNA and protein by NDMA and the effects of PB and PYR pretreatment on alkylation. In control cells, Based on these results, we selected OP and DDC to use as relatively specific inhibitors of cytochrome P450 2B1 and 2E1, alkylation of the cellular macromolecules by NDMA increased with increasing time in culture for~15 h and then leveled respectively, to investigate the relationship between the specific activities of cytochrome P450 2B1 or 2E1 and alkylation by off ( Figure 4A) . Compared to the level of incorporation of radioactivity into control cells, hepatocytes isolated from PB-NDMA, NDPA or NDBA in both the microsomal system and cultured hepatocytes. In control microsomes from untreated pretreated rats exhibited marked decreases in the labeling of DNA, RNA and protein by NDMA ( Figure 4B ). In contrast rats, the pNP hydroxylase activity catalyzed by cytochrome P450 2E1, although low, was measurable, while the cytochrome to the results with PB, PYR-pretreatment significantly increased the alkylation of DNA by NDMA ( Figure 4C ). An unexpected P450 2B1-dependent PR O-depentylase activity could not be detected under our experimental conditions using microsomes result was the observation for the hepatocytes from the PYRpretreated rats exposed to NDMA that the alkylation of the prepared from hepatocytes isolated from untreated rats without fasting before sacrifice. DDC (200 µM) inhibited Ͼ90% of cellular macromolecules was essentially maximal at the first (3 h) time point and that no significant increases in labeling the pNP hydroxylase activity of cytochrome P450 2E1 in untreated microsomes (Table I) . PB pretreatment substantially were seen at subsequent time points. The patterns for the inhibition of NDMA alkylation of DNA, increased the PR O-depentylase activity of cytochrome P450 2B1 and this activity was inhibited by OP by 93%, but was RNA and protein by inhibitors of cytochrome P450 2B1 or 2E1 are presented in Figure 5 . In cell cultures prepared from not effected by co-incubation with DDC (Table I) . Although PYR pretreatment also resulted in a statistically significant untreated or PYR-pretreated rats, both DDC and PYZ resulted found in cultured hepatocytes from PB-pretreated rats ( Figure  6B ). Alkylation of hepatocyte DNA by NDPA was also stimulated by pretreatment of rats with PYR, but the increases were not as great as those seen for alkylation of RNA ( Figure 6C ). Figure 7 shows the effects of DDC, PYZ and OP on the alkylation of DNA, RNA and protein by NDPA. Orphenadrine significantly inhibited the alkylation of DNA, RNA and protein by NDPA in hepatocyte cultures from PB-and PYR-pretreated rats ( Figure 7B and C) ; however, it did not have any inhibitory effect on the alkylation of cellular macromolecules by NDPA in cell cultures from untreated rats ( Figure 7A ). DDC inhibited alkylation of DNA and RNA by NDPA in hepatocytes from untreated and PYR-pretreated rats ( Figure 7A and C), but had of proteins by NDBA ( Figure 8C ). RNA alkylation by NDBA was similar to DNA alkylation in the cultures from untreated rats, but in cultures from PB-or PYR-pretreated rats the initial in significant inhibition of DNA, RNA and protein alkylation, levels of DNA and RNA adducts were relatively high at early whereas OP did not have any effects on NDMA alkylation of time points and did not increase with increasing time of cellular macromolecules ( Figure 5A and C) . We did not find incubation. any statistically significant effects of DDC, PYZ or OP on the The alkylation of hepatocyte DNA, RNA and proteins by alkylation of DNA, RNA and protein by NDMA in cell NDBA was significantly inhibited by OP in cells from PBcultures from PB-pretreated rats ( Figure 5B) . However, the and PYR-pretreated rats (P Ͻ 0.01) ( Figure 9B and C), whereas low levels of metabolism in these cells may have precluded in control cells, OP did not affect DNA, RNA and protein meaningful measurements of inhibition.
alkylation by NDBA ( Figure 9A ). DDC had no significant The ability of NDPA to alkylate cellular DNA, RNA and effect on alkylation of DNA, RNA or proteins by NDBA in proteins of rat hepatocytes is shown in Figure 6 . Exposure of any of the cells. cultured hepatocytes from untreated rats to NDPA produced low but measurable incorporation of radioactivity into DNA, Discussion RNA and protein ( Figure 6A ). Pretreatment with PB or PYR significantly increased the alkylation of hepatocyte DNA and Nitrosodialkylamines have long been thought to induce lethal cellular injuries and initiate carcinogenesis as a result of the RNA by NDPA. A considerable increase in RNA labeling was rats, the alkylation of cellular macromolecules by reactive metabolites of NDMA, NDPA and NDBA was relatively low. The low activities for 14 C-labeling of DNA, RNA and proteins appear to be associated with the relatively low levels of activity of cytochrome P450 2B1 and 2E1, both of which are involved in the metabolism of NDMA, NDPA or NDBA (16,36), in untreated animals. However, induction of cytochrome P450 2B1 and 2E1 by pretreatment of rats with PB and PYR, respectively, or inhibition of the induced enzymes by coincubation with specific inhibitors of cytochrome P450 2B1 or 2E1, significantly affected the total and specific rates for alkylation of DNA, RNA and proteins by NDMA, NDPA and NDBA.
As demonstrated here, pretreatment of rats with PYR pre- P450, e.g. cytochrome P450 2E1, which is responsible for the metabolic activation of NDMA. Unexpectedly, enzyme activity transfer of an alkyl group from the nitrosamine to DNA or possibly RNA (33) (34) (35) . Using 14 C-labeled NDMA, NDPA and assays indicated that in addition to inducing cytochrome P450 2B1 activity, PB pretreatment of rats also led to a statistically NDBA, we compared the covalent binding of these three nitrosodialkylamines to DNA, RNA and proteins in intact rat significant increase in pNP hydroxylation, an activity generally thought to be catalyzed specifically by cytochrome P450 hepatocytes. The various patterns for the labeling of DNA, RNA and proteins of rat hepatocytes exposed to the radio-2E1 (37) . However, our studies with chemical inhibitors demonstrated that cytochrome P450 2E1 was not involved in labeled nitrosamines are of interest because they may prove to be valuable in elucidating the possible mechanism(s) of 4-nitrocatechol formation from pNP by hepatic microsomes from hepatocytes isolated from PB-pretreated rats because carcinogenicity and cytotoxicity of these compounds. Changes in the composition of the cytochromes P450 due to induction/ pNP hydroxylation was not affected at all by preincubation with DDC, a potent and selective inhibitor of P450 2E1 (38) . suppression of expression or enhancement/inhibition of the activity of specific isoforms coincided with striking alterations This observation led us to conclude that there is little or no expression of cytochrome P450 2E1 in hepatocytes isolated in the profiles for the alkylation of cellular macromolecules by the individual nitrosodialkylamines.
from PB-pretreated rats and that cytochrome P450 2E1 is not the sole enzyme capable of catalyzing the hydroxylation of pNP. When incubations were conducted using either hepatic microsomes or cultured hepatocytes isolated from untreated Previous studies have shown that pretreatment of rats with higher levels and may have a poor, but measurable, catalytic activity for the metabolic activation of NDMA. Phenobarbital induced cytochrome P450 2B1, which catalyzes the metabolism of NDPA and NDBA, resulting in increased alkylation of DNA, RNA and protein by these two nitrosamines. In agreement with our previous studies on metabolism and DNA damage by NDPA (16,17), both cytochromes P450 2B1 and 2E1 catalyzed the bioactivation of NDPA. Although cytochrome P450 2B1 played a relatively minor role in the bioactivation of NDPA in rat hepatocytes from untreated animals, it accounted for Ͼ70% of the metabolic activation of NDPA in hepatocytes from PB-and PYRpretreated rats. Cytochrome P450 2E1 only played a significant role in the alkylation of DNA and RNA by NDPA in hepatic microsomes and cultured hepatocytes from untreated and PYR- ing, or isopropylating agent (12,43). It is not known which of these intermediates may be primarily involved in DNA, RNA or protein alkylation, but the alkylation studies strongly suggest PB suppresses liver microsomal demethylation of NDMA (39) consequently reducing NDMA-induced liver tumors (40) . It that these reactive intermediates do not have the same alkylating affinities for hepatocyte DNA, RNA and proteins, or that they has also been shown that P450 2E1 is responsible for the bioactivation of NDMA (41, 42) . Thus, the induction of the are generated at different rates, depending on the activity of different forms of cytochrome P450. The structural differences metabolically unrelated P450 2B1 with the concomitant suppression of expression of P450 2E1, which plays a key role of these reactive intermediates may not only affect their alkylating abilities, but may also determine their abilities to in bioactivation of NDMA, explains the decrease in alkylation by NDMA in rat hepatocytes following PB pretreatment and form specific adducts with cellular DNA, RNA or protein. It has been reported that propylating agents formed from NDPA the reduction in NDMA-induced liver tumors in rats pretreated with PB. However, a low level of pNP hydroxylation and the by P450s are able to alkylate DNA (44) . However, the propyldiazonium ion undergoes rearrangement when it formation of radioactive adducts with DNA, RNA and protein were observed with NDMA upon PB induction. Neither alkylates the O 6 of guanine but no rearrangement is observed when it alkylates the N 7 (44) . The rearrangement observed orphenadrine nor DDC eliminated this catalytic activity, suggesting that an isoform other than 2B1 and 2E1 may be may be due to the fact that the transition state for the reaction at the O 6 is much looser than that for the reaction at the N 7 induced by PB pretreatment at a low level or is induced at P450 2B1 and 2E1 may both catalyze β-hydroxylation of NDPA, but they may also selectively catalyze hydroxylation at different carbon positions and different steps leading to the production of different reactive intermediates (16). These results further support the previous conclusion that both P450 2B1 and 2E1 may play important roles in the metabolic activation and carcinogenesis of NDPA (17).
The alkylation of cellular macromolecules by NDBA was primarily catalyzed by P450 2B1 rather than P450 2E1 in both microsomes and cell cultures. The results of the inhibition studies indicate that P450 2B1 plays an important role in the metabolic activation of NDBA in hepatic microsomes and hepatocytes from PB-and PYR-pretreated rats. However, DNA labeling by NDBA in untreated microsomes was not catalyzed by cytochrome P450 2B1 since OP did not inhibit the low level of 14 C incorporation into DNA from NDBA, suggesting that a constitutive isoform of cytochrome P450 may also play a role in activating NDBA to DNA alkylating agent(s). Further support for the involvement of one or more constitutive isoforms of cytochrome P450 other than 2B1 or 2E1 in metabolism of the nitrosodialkylamines by control animals is seen in Figure 7A . The lack of effect of PYZ and OP on the incorporation of 14 C from NDPA into cellular macromolecules and the limited effect of DDC on the labeling in control animals provides strong evidence for the role of constitutive isoforms of P450 in the metabolism of these nitrosamine carcinogens.
It is not clear how many different reactive metabolites can be formed from NDBA in vivo or in cultured hepatocytes, although n-butyl, oxobutyl and hydroxybutyl cations have been reported to be formed in vivo (45) . Induction of P450 2B1 by PB significantly increased the formation of alkylating agents from NDBA. Unexpectedly, these reactive intermediates of NDBA intensively alkylated hepatic proteins. One possible explanation for the marked increase in protein labeling as compared with DNA labeling could be that the longer alkyl group may not be able to move as rapidly as does a shorter alkyl group from a distant activation site, such as the endoplasmic Furthermore, cytochrome P450 2B1 not only catalyzes the initial step in the bioactivation of NDBA, but it may also be involved in the subsequent activation of proximate metabolites (44) . Therefore, the stability of the reactive metabolites of NDPA or their cellular adducts formed with DNA, RNA or of NDBA to produce a putative methylating agent (16). Since the cellular alterations leading to cancer are generally proteins could also play a role in the observation of different rates for the alkylation of DNA, RNA or protein by NDPA.
thought to be heritable, alkylation of DNA by nitrosodialkylamines is thought to be one of the steps directly involved in the As opposed to the specific activity of NDMA for alkylating DNA, treatment with NDPA resulted in a preponderance of induction of cancers by these carcinogens (18). Therefore, the importance of DNA alkylation by these nitrosodialkylamines the radioactivity being associated with RNA, suggesting that the intracellular target specificity of NDPA differs from that in the induction of cancer deserves consideration. In cultured rat hepatocytes, there is a clear correlation between high rates of NDMA, even though the reactive alkylating metabolites formed from NDMA and NDPA both bind readily to calf of DNA alkylation and high levels of DNA damage induced by NDMA in rat hepatocytes. However, the interaction of thymus DNA in vitro. Increases in the radioactivity incorporated into both DNA and RNA of cells treated with NDPA alkylating agents with RNA, particularly tRNA, might also play a role in the induction of cancer because it is known following induction with PB or PYR indicate that both cytochromes P450 2B1 and 2E1 may play important roles in that certain aspects of cell regulation and differentiation are normally exerted at the level of translation, rather than at the the metabolic activation of NDPA. As previously suggested,
